The medical landscape for blood sugar is evolving, and transdermal GLP-1 delivery systems represent a potential breakthrough. Unlike subcutaneous injections, this approach offers a more convenient way to provide GLP-1 medications. These devices gradually release the treatment through the epidermis offering a stable dose of the active agent, whic… Read More